Nanomix Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nanomix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6471
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosensor. It also offers Nanomix eLab, a point of care testing solution for use in emergency departments and by pre-hospital first responders to speed data availability for faster diagnosis of acute myocardial infarction. Nanomix develops detection devices capable of ultrasensitive, specific and multiplexed detection of proteins, nucleic acids and metabolite chemistries within a single test reaction. It licenses its technology and provides development and manufacturing services for companies that deliver diagnostic products. The company’s services include engineering, chemistry, assay development and performance testing. Nanomix is headquartered in Emeryville, California, the US.

Nanomix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanomix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nanomix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nanomix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nanomix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nanomix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nanomix Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Nanomix Raises US$12 Million In Venture Financing 10
Private Equity 11
Nanomix Raises USD9 Million in Private Equity Financing 11
Partnerships 12
Nanomix Enters into Partnership with RedPharm Biotech and World Technology East 12
Nanomix Inc – Key Competitors 13
Nanomix Inc – Key Employees 14
Nanomix Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Nanomix Inc, Medical Equipment, Key Facts 2
Nanomix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nanomix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nanomix Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nanomix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nanomix Inc, Deals By Market, 2012 to YTD 2018 8
Nanomix Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nanomix Raises US$12 Million In Venture Financing 10
Nanomix Raises USD9 Million in Private Equity Financing 11
Nanomix Enters into Partnership with RedPharm Biotech and World Technology East 12
Nanomix Inc, Key Competitors 13
Nanomix Inc, Key Employees 14

List of Figures
Nanomix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nanomix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nanomix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Nanomix Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nanomix Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nanomix Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nanomix Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nanomix Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nanomix Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Halcon Resources Corp (HK):石油・ガス:M&Aディール及び事業提携情報
    Summary Halcon Resources Corp (Halcon) is an independent energy company that acquires, explores, produces, and develops onshore liquids-rich assets. The company owns and operates its oil and gas explorates resources in El Halcon of Eagle Ford shale formation and Bakken and Three Forks formations. It …
  • PV Crystalox Solar plc (PVCS):企業の財務・戦略的SWOT分析
    PV Crystalox Solar plc (PVCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alligator Bioscience AB (ATORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Alligator Bioscience AB (Alligator Bioscience) is a clinical-stage biotechnology company that discovers and develops antibody based pharmaceuticals for the treatment of cancer. The company’s pipeline products include ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527. The ADC-1013, currently und …
  • Abbott Diabetes Care Inc-医療機器分野:企業M&A・提携分析
    Summary Abbott Diabetes Care Inc (ADC), formerly TheraSense Inc, a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company’s products include glucose monitor …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Kikkoman Corp:企業の戦略・SWOT・財務分析
    Kikkoman Corp - Strategy, SWOT and Corporate Finance Report Summary Kikkoman Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Nissin Foods Holdings Co Ltd (2897):企業の財務・戦略的SWOT分析
    Nissin Foods Holdings Co Ltd (2897) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Swift Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company offers products such as 2S DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Corium International Inc (CORI):製薬・医療:M&Aディール及び事業提携情報
    Summary Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products i …
  • Peptimimesis SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Peptimimesis SAS (Peptimimesis) is a biopharmaceutical company that discovers and develops transmembrane therapeutic peptides. The company’s proprietary platform delivers a set of drug candidates that act on strategic targets in the field of immuno-oncology, oncology and immune diseases. Its …
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Verrica Pharmaceuticals Inc (VRCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Verrica Pharmaceuticals Inc (Verrica) is a clinical-stage medical dermatology company that discovers, develops and commercializes therapeutics for the treatment of skin diseases. The company’s lead product candidate, VP-102, is in two phase 3 clinical trials for the treatment of molluscum co …
  • Pfizer Ltd India (PFIZER):企業の財務・戦略的SWOT分析
    Summary Pfizer Ltd India (Pfizer India) a subsidiary of Pfizer Inc, operates as a pharmaceutical company that develops medicines for brain disorders. The company’s products portfolio comprises of anti-allergics, anti-diabetics, anti-histamines, anti-infectives, anti-parasitics, drugs for cardiovascu …
  • OAO Gazprom:企業の戦略・SWOT・財務情報
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Mendor Oy-製薬・医療分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Culver Franchising System Inc:企業の戦略・SWOT・財務情報
    Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report Summary Culver Franchising System Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Everist Genomics Inc-医療機器分野:企業M&A・提携分析
    Summary Everist Genomics Inc (Everest Health), formerly Genetics Squared Inc is a developer of prognostics, medical diagnostic and therapeutic selection technologies. The company provides angiodefender cardiovascular disease diagnostic system, a non invasive device that is used for combining sensor …
  • Probiogen AG-製薬・医療分野:企業M&A・提携分析
    Summary Probiogen AG (Probiogen), a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆